Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Rep ; 41(11): 111817, 2022 12 13.
Article in English | MEDLINE | ID: mdl-36516756

ABSTRACT

During mycobacterial infections, pathogenic mycobacteria manipulate both host immune and stromal cells to establish and maintain a productive infection. In humans, non-human primates, and zebrafish models of infection, pathogenic mycobacteria produce and modify the specialized lipid trehalose 6,6'-dimycolate (TDM) in the bacterial cell envelope to drive host angiogenesis toward the site of forming granulomas, leading to enhanced bacterial growth. Here, we use the zebrafish-Mycobacterium marinum infection model to define the signaling basis of the host angiogenic response. Through intravital imaging and cell-restricted peptide-mediated inhibition, we identify macrophage-specific activation of NFAT signaling as essential to TDM-mediated angiogenesis in vivo. Exposure of cultured human cells to Mycobacterium tuberculosis results in robust induction of VEGFA, which is dependent on a signaling pathway downstream of host TDM detection and culminates in NFATC2 activation. As granuloma-associated angiogenesis is known to serve bacterial-beneficial roles, these findings identify potential host targets to improve tuberculosis disease outcomes.


Subject(s)
Mycobacterium marinum , Mycobacterium tuberculosis , Tuberculosis , Animals , Humans , Zebrafish/microbiology , Macrophages/metabolism , Signal Transduction , Granuloma/pathology , NFATC Transcription Factors/metabolism
2.
J Virol ; 96(4): e0203921, 2022 02 23.
Article in English | MEDLINE | ID: mdl-34878926

ABSTRACT

The single-stranded DNA genome of adeno-associated viruses (AAV) undergoes second-strand synthesis and transcription in the host cell nucleus. While wild-type AAV genomes are naturally silenced upon integration into the host genome, recombinant AAV (rAAV) genomes typically provide robust expression of transgenes persisting as extrachromosomal DNA or episomes. Episomal DNA associating with host histones is subject to epigenetic modifications, although the mechanisms underlying such are not well understood. Here, we provide evidence that the double-stranded DNA binding protein NP220, in association with the human silencing hub (HUSH) complex, mediates transcriptional silencing of single-stranded as well as self-complementary rAAV genomes. In cells lacking NP220 or other components of the HUSH complex, AAV genome transcript levels are increased and correlate with a marked reduction in repressive H3K9 histone methylation marks. We also provide evidence that the AAV capsid (serotype) can profoundly influence NP220-mediated silencing of packaged genomes, indicating potential role(s) for capsid-genome or capsid-host factor interactions in regulating epigenetic silencing of rAAV genomes. IMPORTANCE Recombinant AAV vectors can enable long-term gene expression in a wide variety of tissues. However, transgene silencing has been reported in some human gene therapy clinical trials. Here, we demonstrate the HUSH complex can suppress transcript formation from rAAV vector genomes by epigenetic modification of associated host histones. Further, the AAV capsid appears to play an important role in this pathway. We postulate that modulation of epigenetic pathways could help improve rAAV expression.


Subject(s)
DNA-Binding Proteins/metabolism , Dependovirus/genetics , Gene Silencing , Genome, Viral/genetics , Multiprotein Complexes/metabolism , RNA-Binding Proteins/metabolism , Transcription Factors/metabolism , Antigens, Neoplasm/genetics , Antigens, Neoplasm/metabolism , Capsid/metabolism , DNA-Binding Proteins/genetics , Dependovirus/metabolism , Epigenesis, Genetic , HEK293 Cells , Humans , Multiprotein Complexes/genetics , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , RNA-Binding Proteins/genetics , Serogroup , Transcription Factors/genetics , Transcription, Genetic , Transgenes/genetics
3.
J Cell Sci ; 134(8)2021 04 15.
Article in English | MEDLINE | ID: mdl-33722979

ABSTRACT

CRISPR/Cas9-based tissue-specific knockout techniques are essential for probing the functions of genes in embryonic development and disease using zebrafish. However, the lack of capacity to perform gene-specific rescue or live imaging in the tissue-specific knockout background has limited the utility of this approach. Here, we report a robust and flexible gateway system for tissue-specific gene inactivation in neutrophils. Using a transgenic fish line with neutrophil-restricted expression of Cas9 and ubiquitous expression of single guide (sg)RNAs targeting rac2, specific disruption of the rac2 gene in neutrophils is achieved. Transient expression of sgRNAs targeting rac2 or cdk2 in the neutrophil-restricted Cas9 line also results in significantly decreased cell motility. Re-expressing sgRNA-resistant rac2 or cdk2 genes restores neutrophil motility in the corresponding knockout background. Moreover, active Rac and force-bearing F-actins localize to both the cell front and the contracting tail during neutrophil interstitial migration in an oscillating fashion that is disrupted when rac2 is knocked out. Together, our work provides a potent tool that can be used to advance the utility of zebrafish in identifying and characterizing gene functions in a tissue-specific manner.


Subject(s)
Neutrophils , Zebrafish , Animals , Animals, Genetically Modified , CRISPR-Cas Systems/genetics , Clustered Regularly Interspaced Short Palindromic Repeats/genetics , Neutrophils/metabolism , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism , rac GTP-Binding Proteins/metabolism
4.
Elife ; 82019 01 29.
Article in English | MEDLINE | ID: mdl-30693866

ABSTRACT

Mycobacterium tuberculosis is the leading worldwide cause of death due to a single infectious agent. Existing anti-tuberculous therapies require long treatments and are complicated by multi-drug-resistant strains. Host-directed therapies have been proposed as an orthogonal approach, but few have moved into clinical trials. Here, we use the zebrafish-Mycobacterium marinum infection model as a whole-animal screening platform to identify FDA-approved, host-directed compounds. We identify multiple compounds that modulate host immunity to limit mycobacterial disease, including the inexpensive, safe, and widely used drug clemastine. We find that clemastine alters macrophage calcium transients through potentiation of the purinergic receptor P2RX7. Host-directed drug activity in zebrafish larvae depends on both P2RX7 and inflammasome signaling. Thus, targeted activation of a P2RX7 axis provides a novel strategy for enhanced control of mycobacterial infections. Using a novel explant model, we find that clemastine is also effective within the complex granulomas that are the hallmark of mycobacterial infection.


Subject(s)
Antitubercular Agents/pharmacology , Clemastine/pharmacology , Granuloma/drug therapy , Mycobacterium Infections, Nontuberculous/drug therapy , Receptors, Purinergic P2X7/genetics , Zebrafish Proteins/genetics , Animals , Anti-Allergic Agents/pharmacology , Calcium/immunology , Calcium/metabolism , Disease Models, Animal , Drug Repositioning , Gene Expression Regulation , Granuloma/genetics , Granuloma/immunology , Granuloma/microbiology , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Humans , Immunity, Innate/drug effects , Inflammasomes , Larva/drug effects , Larva/genetics , Larva/immunology , Larva/microbiology , Macrophages/drug effects , Macrophages/immunology , Macrophages/microbiology , Mycobacterium Infections, Nontuberculous/genetics , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/growth & development , Mycobacterium marinum/immunology , Mycobacterium marinum/pathogenicity , Mycobacterium tuberculosis/pathogenicity , Receptors, Purinergic P2X7/immunology , Signal Transduction , Tissue Culture Techniques , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/microbiology , Zebrafish/genetics , Zebrafish/immunology , Zebrafish/microbiology , Zebrafish Proteins/agonists , Zebrafish Proteins/immunology
5.
Cell Host Microbe ; 24(4): 514-525.e6, 2018 10 10.
Article in English | MEDLINE | ID: mdl-30308157

ABSTRACT

Mycobacterial infection leads to the formation of characteristic immune aggregates called granulomas, a process accompanied by dramatic remodeling of the host vasculature. As granuloma angiogenesis favors the infecting mycobacteria, it may be actively promoted by bacterial determinants during infection. Using Mycobacterium marinum-infected zebrafish as a model, we identify the enzyme proximal cyclopropane synthase of alpha-mycolates (PcaA) as an important bacterial determinant of granuloma-associated angiogenesis. cis-Cyclopropanation of mycobacterial mycolic acids by pcaA drives the activation of host Vegf signaling within granuloma macrophages. Cyclopropanation of the mycobacterial cell wall glycolipid trehalose dimycolate is both required and sufficient to induce robust host angiogenesis. Inducible genetic inhibition of angiogenesis and Vegf signaling during granuloma formation results in bacterial growth deficits. Together, these data reveal a mechanism by which PcaA-mediated cis-cyclopropanation of mycolic acids promotes bacterial growth and dissemination in vivo by eliciting granuloma vascularization and suggest potential approaches for host-directed therapies.


Subject(s)
Bacterial Proteins/metabolism , Methyltransferases/metabolism , Mycobacterium marinum/enzymology , Neovascularization, Pathologic/microbiology , Receptors, Vascular Endothelial Growth Factor/metabolism , Tuberculoma/microbiology , Angiogenesis Inhibitors/pharmacology , Animals , Bacterial Proteins/genetics , Cord Factors/metabolism , Disease Models, Animal , Humans , Indazoles , Macrophages/immunology , Macrophages/microbiology , Methyltransferases/genetics , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/genetics , Mycobacterium marinum/pathogenicity , Mycolic Acids/metabolism , Neovascularization, Pathologic/immunology , Neovascularization, Pathologic/pathology , Pyrimidines/pharmacology , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Receptors, Vascular Endothelial Growth Factor/drug effects , Signal Transduction , Sulfonamides/pharmacology , Tuberculoma/immunology , Tuberculoma/pathology , Zebrafish
6.
Proc Natl Acad Sci U S A ; 114(37): E7746-E7755, 2017 09 12.
Article in English | MEDLINE | ID: mdl-28827342

ABSTRACT

Risk, severity, and outcome of infection depend on the interplay of pathogen virulence and host susceptibility. Systematic identification of genetic susceptibility to infection is being undertaken through genome-wide association studies, but how to expeditiously move from genetic differences to functional mechanisms is unclear. Here, we use genetic association of molecular, cellular, and human disease traits and experimental validation to demonstrate that genetic variation affects expression of VAC14, a phosphoinositide-regulating protein, to influence susceptibility to Salmonella enterica serovar Typhi (S Typhi) infection. Decreased VAC14 expression increased plasma membrane cholesterol, facilitating Salmonella docking and invasion. This increased susceptibility at the cellular level manifests as increased susceptibility to typhoid fever in a Vietnamese population. Furthermore, treating zebrafish with a cholesterol-lowering agent, ezetimibe, reduced susceptibility to S Typhi. Thus, coupling multiple genetic association studies with mechanistic dissection revealed how VAC14 regulates Salmonella invasion and typhoid fever susceptibility and may open doors to new prophylactic/therapeutic approaches.


Subject(s)
Membrane Proteins/genetics , Membrane Proteins/metabolism , Salmonella typhi/genetics , Cell Line, Tumor , Cholesterol/genetics , Cholesterol/metabolism , Ezetimibe , Genetic Variation/genetics , Genome-Wide Association Study , Humans , Intracellular Signaling Peptides and Proteins , Polymorphism, Single Nucleotide , Salmonella/genetics , Salmonella/pathogenicity , Salmonella typhi/metabolism , Salmonella typhi/pathogenicity , Typhoid Fever/metabolism , Typhoid Fever/physiopathology , Virulence/genetics
7.
PLoS One ; 10(10): e0138949, 2015.
Article in English | MEDLINE | ID: mdl-26445458

ABSTRACT

Transgenic labeling of innate immune cell lineages within the larval zebrafish allows for real-time, in vivo analyses of microbial pathogenesis within a vertebrate host. To date, labeling of zebrafish macrophages has been relatively limited, with the most specific expression coming from the mpeg1 promoter. However, mpeg1 transcription at both endogenous and transgenic loci becomes attenuated in the presence of intracellular pathogens, including Salmonella typhimurium and Mycobacterium marinum. Here, we describe mfap4 as a macrophage-specific promoter capable of producing transgenic lines in which transgene expression within larval macrophages remains stable throughout several days of infection. Additionally, we have developed a novel macrophage-specific Cre transgenic line under the control of mfap4, enabling macrophage-specific expression using existing floxed transgenic lines. These tools enrich the repertoire of transgenic lines and promoters available for studying zebrafish macrophage dynamics during infection and inflammation and add flexibility to the design of future macrophage-specific transgenic lines.


Subject(s)
Host-Pathogen Interactions/genetics , Macrophages/microbiology , Mycobacterium Infections/genetics , Promoter Regions, Genetic/genetics , Zebrafish Proteins/genetics , Zebrafish/genetics , Zebrafish/microbiology , Animals , Animals, Genetically Modified/genetics , Animals, Genetically Modified/microbiology , Cell Lineage/genetics , Disease Models, Animal , Immunity, Innate/genetics , Larva/genetics , Larva/microbiology , Mycobacterium Infections/microbiology , Mycobacterium marinum/pathogenicity , Salmonella typhimurium/pathogenicity , Transgenes/genetics
8.
Nature ; 517(7536): 612-5, 2015 Jan 29.
Article in English | MEDLINE | ID: mdl-25470057

ABSTRACT

Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis. Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis. Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations. Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/drug effects , Mycobacterium marinum/growth & development , Neovascularization, Pathologic/microbiology , Signal Transduction/drug effects , Zebrafish/microbiology , Angiogenesis Inhibitors/therapeutic use , Animals , Antibiotics, Antitubercular/pharmacology , Bacterial Load/drug effects , Disease Models, Animal , Drug Synergism , Granuloma/drug therapy , Granuloma/metabolism , Granuloma/microbiology , Granuloma/pathology , Hypoxia/metabolism , Hypoxia/microbiology , Hypoxia/pathology , Larva/drug effects , Larva/microbiology , Macrophages/metabolism , Macrophages/microbiology , Macrophages/pathology , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/metabolism , Mycobacterium Infections, Nontuberculous/pathology , Mycobacterium marinum/pathogenicity , Neovascularization, Pathologic/drug therapy , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Receptors, Vascular Endothelial Growth Factor/metabolism , Tuberculosis/drug therapy , Tuberculosis/microbiology , Tuberculosis/pathology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/metabolism , Zebrafish/growth & development
9.
J Colloid Interface Sci ; 345(2): 556-60, 2010 May 15.
Article in English | MEDLINE | ID: mdl-20227085

ABSTRACT

Low molecular weight organic acids comprise an important pool of reactive ligands in aquatic systems. These acids readily bind to nano-sized mineral particles and thereby strongly influence a particle's physicochemical behavior. Predicting this influence requires the integration of molecular-level details that control surface complexation mechanisms and structures with macro-scale observations of mineral colloid behavior. We report on the aggregation kinetics of nano-sized hematite in the presence of fumaric acid and maleic acid, which are naturally occurring dicarboxylic acids of similar size and structure. Our results indicate that the structure and orientation of the adsorbed dianion at the hematite surface, not the adsorption mechanism, defines the resulting effect. Maleate, which directs both carboxyl groups to the surface in the form of inner- and outer-sphere surface complexes, enhances colloidal stability. Fumarate, however, which binds to the hematite surface as an outer-sphere complex with just one carboxyl group only slightly influenced particle stability. This outcome suggests that subtle differences in the structure of adsorbed acids produce important differences in the physicochemical behavior of particles in dilute aquatic systems.


Subject(s)
Ferric Compounds/chemistry , Fumarates/chemistry , Magnetite Nanoparticles/chemistry , Maleates/chemistry , Adsorption , Colloids , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...